{"name": "Eyevensys",
 "permalink": "eyevensys",
 "crunchbase_url": "http://www.crunchbase.com/company/eyevensys",
 "homepage_url": "http://www.eyevensys.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Mon Apr 01 04:38:58 UTC 2013",
 "updated_at": "Fri Apr 12 12:44:15 UTC 2013",
 "overview": "\u003Cp\u003EEyevensys created in 2009 is headquartered in Paris, France. It develops and will commercialize patented, minimally invasive, targeted, non-viral gene therapy-based solutions for the sustainable intraocular production of any secreted therapeutic protein or peptide.\nEYEVENSYS\u2019s technology consists of a patented device that allows the calibrated injection in the ciliary muscle of a plasmid containing the gene encoding for a therapeutic peptide or protein. The sustainability of the gene expression is induced thanks to a patented proprietary electrotransfer technology or corticostranfection technology. The ciliary muscle is used for the transfection of therapeutic genes, playing then the role of a \u201cfactory\u201d for the intraocular production of gene therapies, that will spread to the overall eye sphere, particularly into the vitreous cavity.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       62],
      "assets/images/resized/0024/6830/246830v1-max-150x150.png"],
     [[250,
       103],
      "assets/images/resized/0024/6830/246830v1-max-250x250.png"],
     [[337,
       140],
      "assets/images/resized/0024/6830/246830v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Ivan",
      "last_name": "Cohen-Tanugi",
      "permalink": "ivan-cohen-tanugi",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2013/04/eyevensys-raises-funds-boehringer-ingelheim-venture-fund.html",
    "source_description": "Eyevensys Raises Funds from Boehringer Ingelheim Venture Fund",
    "raised_amount": null,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Boehringer Ingelheim Venture Fund",
         "permalink": "boehringer-ingelheim-venture-fund",
         "image":
          {"available_sizes":
            [[[135,
               40],
              "assets/images/resized/0023/2429/232429v2-max-150x150.png"],
             [[135,
               40],
              "assets/images/resized/0023/2429/232429v2-max-250x250.png"],
             [[135,
               40],
              "assets/images/resized/0023/2429/232429v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "67 rue Saint-Jacques",
    "address2": "",
    "zip_code": "75005 ",
    "city": "Paris",
    "state_code": null,
    "country_code": "FRA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[120,
        150],
       "assets/images/resized/0024/6829/246829v1-max-150x150.png"],
      [[201,
        250],
       "assets/images/resized/0024/6829/246829v1-max-250x250.png"],
      [[362,
        450],
       "assets/images/resized/0024/6829/246829v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}